M&A Strategy Research In Multinational Pharmaceutical Companies

The development of enterprises, the need for capital expansion. And the expansion ofcapital, to the expansion of the comprehensive use of various effective form. Mergers as thechange of social economy, the capital expansion mode gradually, and penetrated into allwalks of life, become an important based on the development of the industry. It was the sameas for multinational pharmaceutical companies. And the continuous development of medicalenterprise, but also accelerate the steps of the application of joint-venture mergers andacquisitions in the pharmaceutical industry. However, each industry joint venture mergermode is not the same, the health care industry joint venture merger mode will inevitably havesome industry characteristics. And the development of pharmaceutical enterprises by the lowsuccess rate and long payback period of r&d, pharmaceutical enterprise development patternhas its corresponding characteristics, many enterprises in the face of mergers are noexperience can be for reference, can only touch stone across the river, this paper is to verifythe joint venture merger and acquisition strategy in the development of pharmaceuticalindustry in terms of value. Based on the research of the joint venture merger strategies formultinational pharmaceutical companies related practice in order to provide the valuablereference.In the process of research, this article first briefly introduced the relevant theories ofmergers, the tone for the whole study lay a good theory. On this basis, the multinationalpharmaceutical enterprises as the research object, the mergers of the basic features of a briefanalysis of the industry of joint acquisition strategy of the basic requirements and ideas. Then,based on the PFE company as an example, has carried on the empirical research, the systemjoint acquisition strategy is discussed, and the specific content. Finally, we summarized in thispaper, the research content and conclusion, the final conclusion. This study argues thatmergers multinational pharmaceutical enterprises implement strategy, can increase the size ofthe original and keep the profit growth, mergers might as well look for research anddevelopment orientation of target company, so based on the essence of expansion, andsolution to analyze the business long-term development bottleneck. At the same time, muststrengthen the funds after the merger integration, to ensure that all mergers and acquisitions the capa to effect. Out of respect for generality and individual character, this paper firstanalyzes the general enterprise merger and acquisition of target selection and integration ofthe common problems in the process, after the analysis of the pharmaceutical industry in thetarget selection and special problems in the process of m&a integration. Will integrate the twotypes of problems, for multinational pharmaceutical joint venture of enterprise merger andacquisition activity to provide objective basis.